Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...
New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life's unique antibody fragment-based platform Agreement provides potential for up to approx.
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
BostonGene, developer of the leading AI foundation model for cancer and the immune system, today announced that it will showcase its latest advances at the Association for Molecular Pathology (AMP) ...
Optigo Biotherapeutics (“Optigo”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its ...
Grist on MSN
As aid dries up in Kenya, millions are threatened by the climate-driven disease kala-azar
Rising temperatures and erratic rainfall have supercharged the breeding of sandflies that spread the climate-driven disease ...
Marius Pharmaceuticals, Inc., today announced the formation of an all-female advisory board to advance the company’s efforts in addressing the significant unmet ...
Gardening Know How on MSN
Is Your Plant Dying or Just Taking a Nap? 5 Signs Plants Are Dormant – and When to Act
Bare stems, yellow leaves, no new growth? Don’t panic! Dormancy is nature’s way of recharging. But what is dormancy in plants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback